Organization Address
Accounts Payable PO Box 30147
College Station, TX 77842

Organization Phone
(650) 228-1880


Biotech and Pharmaceutical

Organization Description

Sanofi-Aventis is an international pharmaceutical group engaged in the research, development, manufacture and marketing of pharmaceutical products for sale principally in the prescription market. Sanofi-Avenits specializes in seven therapeutic areas: cardiovascular, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines. The Company’s five strategic products Aprovel, Eloxatin, Plavix, Stilnox and Xatral, together, accounted for 54.7% of total consolidated net sales during the year ended December 31, 2003. In addition, Sanofi-Avenits has 56 compounds in development in the four therapeutic areas, 25 of which were in Phase II or Phase III clinical trials. The Company also manufactures and markets a variety of generics in France, Germany and the United Kingdom. On August 20, 2004, Sanofi-Synthelabo merged with Aventis, and changed its name from Sanofi-Synthelabo to Sanofi-Aventis.